12.22.25 -- CEOs Talk FDA, China, Funding Sources

Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.

See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.

Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

To strengthen cross-functional performance, teams should commit to building shared understanding, improving communication, and continuously refining their approach.

A modular cell line development platform helps overcome biologic complexity. Learn how flexibility and expert support drive success from early development through commercial manufacturing.

Drawing on insights from real-world studies and behavioral health programs, this session provides a practical roadmap for turning a patient’s “no” into an informed, empowered “yes.”

To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.

This comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.

Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.